Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies

B Cuglievan, J Connors, J He, S Khazal, S Yedururi… - Leukemia, 2023 - nature.com
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy that
can involve the bone marrow, peripheral blood, skin, lymph nodes, and the central nervous …

Plasmacytoid dendritic cells in the setting of myeloid neoplasms: Diagnostic guide to challenging pathologic presentations

S El Hussein, W Wang - British Journal of Haematology, 2023 - Wiley Online Library
In this article, we describe three broad pathologic presentations of plasmacytoid dendritic
cells (pDCs) that may be encountered in clinical practice, in which an association between …

[HTML][HTML] Progression in myeloid neoplasms: beyond the myeloblast

C Faria, A Tzankov - Pathobiology, 2024 - karger.com
Disease progression in myelodysplastic syndromes (MDS), myelodysplastic-
myeloproliferative neoplasms (MDS/MPN), and myeloproliferative neoplasms (MPN) …

Coincidence of cutaneous blastic plasmacytoid dendritic cell neoplasm and myelodysplastic syndrome derived from clonal hematopoiesis

T Yamada, N Hiramoto, T Mori, D Yamashita… - Blood Cancer …, 2023 - nature.com
Dear Editor, Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare neoplasm
derived from plasmacytoid dendritic cells of myeloid origin [1]. Karyotypic abnormalities are …

Blastic Plasmacytoid Dendritic Cell Neoplasm, from a Dermatological Point of View

C Di Raimondo, F Lozzi, PP Di Domenico… - International Journal of …, 2024 - mdpi.com
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive hematological
malignancy derived from the precursors of plasmacytoid dendritic cells. Although disease …

[HTML][HTML] Real-world evidence on tagraxofusp for blastic plasmacytoid dendritic cell neoplasm–collected cases from a single center and case reports

P Faustmann, JC Schroeder, L Mix, L Harland… - Frontiers in …, 2024 - ncbi.nlm.nih.gov
Methods Here, we report real-world outcomes of five male patients with a median age of 79
years who received tagraxofusp as first-line treatment for BPDCN. Results Tagraxofusp was …

Flow Cytometry Profiling of Plasmacytoid Dendritic Cell Neoplasms

S El Hussein, W Wang - Cancers, 2024 - mdpi.com
Simple Summary There are three main types of neoplastic plasmacytoid dendritic cell (pDC)
proliferations: blastic plasmacytoid dendritic cell neoplasm (BPDCN), acute myeloid …

Clinical Flow Cytometry Analysis in the Setting of Chronic Myeloid Neoplasms and Clonal Hematopoiesis

S El Hussein, S Loghavi - Clinics in Laboratory Medicine, 2023 - labmed.theclinics.com
Chronic myeloid neoplasms including myelodysplastic neoplasms (MDS) and
myeloproliferative neoplasms (MPNs) are clonal hematopoietic stem cell (HSC) disorders …